OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Netflix Is Testing Log-In Warnings to Curb Unauthorized Password Sharing

March 11, 2021

Netflix may be finally getting serious about cracking down on password sharing. The streaming giant in the past week launched a new test that displays a...

3rdPartyFeeds

Dow Jones Climbs While Tech Stocks Lead Market Higher; These Dow Stocks Near Buy Zones

March 11, 2021

The Dow Jones Industrial Average climbed higher in today's stock market while both the blue chip index and the S&P 500 notched new intraday highs. Read...

3rdPartyFeeds • News

: Is there a new commodity supercycle? Maybe not, these analysts say.

March 11, 2021

Commodity prices — across food, energy and metals — are undeniably rising. But that doesn't mean there's a supercycle.

Read More...

3rdPartyFeeds • News

The Tell: Active managers underperformed stock indexes in 2020, S&P’s SPIVA report finds

March 11, 2021

A majority of U.S. equity funds lagged the S&P 500 index during 2020, according to a closely-watched annual report from S&P Dow Jones Indices. Read...

3rdPartyFeeds

Why You Should Own Biotech Stocks Now

March 11, 2021

The confluence of healthcare and technology will send many biotech stocks soaring over the next decade. Read More...

3rdPartyFeeds

CGC Stock A Buy? Canopy Growth Slumps After February Rally But Profit Outlook Improves

March 11, 2021

Canopy Growth, the largest marijuana stock, has fallen after a post-election rally. But the profit outlook is clearer. Is CGC stock a buy right now? Read More...

3rdPartyFeeds

The Nasdaq’s Back, and These 3 Stocks Are Flying High Again

March 11, 2021

The stock market has been going through a lot of volatility lately, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) has found itself on the short end of the...

3rdPartyFeeds • News

: Rolls-Royce hopes $5.6 billion 2020 loss leaves ‘the worst behind’

March 11, 2021

The British engine maker and supplier of parts to the airline industry, announced a worse-than-expected loss for 2020, but said it is still confident it can...

3rdPartyFeeds • News

The Conversation: The backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky — here’s exactly how to make the rollout a success

March 11, 2021

The one-shot vaccine from Johnson & Johnson could be a game-changer, but perceptions that it is inferior must be actively dispelled

Read More...

3rdPartyFeeds

Dow Jones Hits Record High With Biden Set To Sign Covid Stimulus Bill; Roblox Stock Jumps

March 11, 2021

The Dow Jones rose on encouraging new data. IPO stock Roblox stock was surging again. Tesla and Nio charged higher, while Apple also gained. Read More...

Previous 1 … 4,691 4,692 4,693 4,694 4,695 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.